|
Market Closed -
OTC Markets
10:01:28 04/06/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.0290 USD | +6.62% |
|
+107.14% | -52.77% |
| 14/08 | CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 14/08 | CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 32.52L 28.6L 26.96L 24.6L 46.01L 31Cr 46.37L 3.24Cr 1.25Cr 16Cr 1.22Cr 1.19Cr 52Cr | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 49.7L 43.72L 41.21L 37.6L 70.31L 48Cr 70.86L 4.95Cr 1.92Cr 24Cr 1.87Cr 1.83Cr 79Cr | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
78.62% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CV Sciences, Inc.
| 1 day | +6.62% | ||
| 1 week | +107.14% | ||
| Current month | +55.08% | ||
| 1 month | +55.91% | ||
| 3 months | +31.82% | ||
| 6 months | -21.41% | ||
| Current year | -52.77% |
| 1 week | 0.01 |  | 0.03 |
| 1 month | 0.01 | | 0.03 |
| Current year | 0.01 | | 0.1 |
| 1 year | 0.01 | | 0.1 |
| 3 years | 0.01 | | 0.1 |
| 5 years | 0.01 | | 0.27 |
| 10 years | 0.01 | | 9.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 31/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 15/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 31/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 21/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 21/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/02/25 | Free | Chief Executive Officer | 30,00,000 | 1.6281% | ||
| 18/02/25 | Free | Director | 5,00,000 | 0.2714% | ||
| 18/02/25 | Free | Director | 5,00,000 | 0.2714% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.62% | +107.14% | -14.71% | -36.78% | 32.52L | |
| +2.68% | +2.56% | +59.32% | +114.68% | 1,05300Cr | |
| +0.56% | +0.17% | +53.19% | +68.65% | 65TCr | |
| +0.02% | +0.42% | +20.51% | +73.58% | 47TCr | |
| -0.65% | +1.15% | +41.53% | +44.62% | 35TCr | |
| +0.28% | +3.75% | +21.86% | +29.10% | 27TCr | |
| +0.48% | -0.32% | +13.73% | +11.31% | 25TCr | |
| -0.01% | +6.91% | +45.42% | +51.68% | 22TCr | |
| -1.11% | -0.80% | +31.69% | +99.56% | 19TCr | |
| +0.10% | -9.93% | -29.77% | -60.20% | 17TCr | |
| Average | +0.87% | +0.27% | +24.28% | +39.62% | 36.27TCr | |
| Weighted average by Cap. | +0.29% | +1.00% | +39.04% | +67.85% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.57Cr 1.38Cr 1.3Cr 1.19Cr 2.22Cr 150.76Cr 2.24Cr 16Cr 6.06Cr 77Cr 5.9Cr 5.77Cr 249.68Cr | 1.38Cr 1.21Cr 1.14Cr 1.04Cr 1.95Cr 132.36Cr 1.97Cr 14Cr 5.32Cr 67Cr 5.18Cr 5.06Cr 219.22Cr |
| Net income | -23.94L -21.06L -19.85L -18.11L -33.87L -23Cr -34.13L -2.38Cr -92.31L -12Cr -89.89L -87.93L -38Cr | -10L -8L -8L -7L -13.55L -9.2Cr -13.66L -95.32L -36.94L -4.68Cr -35.97L -35.19L -15Cr |
| Net Debt | 3L 3L 3L 2L 5L 3.12Cr 5L 32.34L 12.53L 1.59Cr 12.2L 11.94L 5.17Cr | 17.18L 15.11L 14.25L 13L 24.31L 16Cr 24.5L 1.71Cr 66.24L 8.39Cr 64.5L 63.1L 27Cr |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | $0.0144 | +10.77% | 12,33,798 |
| 23/26/23 | $0.0130 | -13.33% | 11,07,468 |
| 22/26/22 | $0.0150 | +7.14% | 2,02,195 |
| 21/26/21 | $0.0140 | -.--% | 6,75,174 |
| 18/26/18 | $0.0140 | -.--% | 17,41,848 |
- Stock Market
- Stocks
- CVSI Stock
Select your edition
All financial news and data tailored to specific country editions
